Stroke incidence and anticoagulation treatment in patients with pacemaker-detected silent atrial fibrillation

Emma Sandgren1,2, Cecilia Rorsman1, Nils Edvardsson3

  • 1Department of Medicine, Halland Hospital Varberg, Varberg, Sweden.

Plos One
|September 14, 2018
PubMed

Insights

Silent atrial fibrillation (AF) is common, and anticoagulation may reduce stroke risk. Further research is needed to determine optimal treatment for patients with silent AF.

Area of Science:

  • Cardiology
  • Neurology

Background:

  • Silent atrial fibrillation (AF) is prevalent, yet its optimal management, particularly anticoagulation, remains debated.
  • Patients with pacemakers are at risk for developing silent AF.

Purpose of the Study:

  • To investigate the incidence of silent AF in pacemaker patients.
  • To assess the impact of anticoagulation on stroke and dementia risk in patients with and without AF.

Main Methods:

  • Retrospective analysis of consecutive patients with dual-chamber pacemakers.
  • Recording of silent AF development, anticoagulation status, and incidence of ischemic stroke and dementia.

Main Results:

  • 30% of patients without known AF at implant developed silent AF during follow-up.
  • Stroke incidence was similar in patients with known AF (2.1%) and silent AF (1.9%).
  • Vascular dementia was more common in patients with known AF (11.2%) compared to those without AF (6.2%).

Conclusions:

  • Anticoagulation may significantly reduce stroke risk in patients with silent AF.
  • Vascular dementia risk is elevated in patients with known AF.
  • More data is required to guide optimal anticoagulation strategies for silent AF.
Abstract

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.0K
Amyloid Fibrils03:03

Amyloid Fibrils

6.4K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.4K
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.9K
Fibril-associated Collagen01:11

Fibril-associated Collagen

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
3.4K
Types of Reports II: Incident or Occurrence Report01:21

Types of Reports II: Incident or Occurrence Report

An Incident or Occurrence Report in a healthcare setting is a crucial document used to record any unexpected occurrence that may or may not have affected a patient, employee, or visitor. Such reports are critical to improving patient safety and include all details leading up to and including the event.
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
1.3K